Lanzamiento Enero 2027

Ensayo controlado aleatorizado2011Financiación no declarada

Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease

Shechter M, Shalmon G, Scheinowitz M, Koren-Morag N, Feinberg MS, Harats D, Sela BA, Sharabi Y, Chouraqui P

The American journal of cardiology · 50 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2011-02-24 · Am J Cardiol · vol. 107 · número 9 · págs. 1255–1261
Editorial
Elsevier BV
Citado
74 citas · más que el 92% de estudios similares · 3.5× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
32 trabajos
Acceso
De pago
Áreas de investigación
Coffee research and impacts · Cardiovascular Health and Disease Prevention · Nitric Oxide and Endothelin Effects
Palabras clave
acute caffeine ingestion, endothelial function, coronary artery disease, flow-mediated dilation, nitroglycerin-mediated dilation, brachial artery, C-reactive protein, inflammation, coffee, cardiovascular risk factors
MeSH
brachial artery, endothelium, vascular, humans, caffeine, phosphodiesterase inhibitors, case-control studies, double-blind method, regional blood flow, middle aged, female, male, coronary artery disease, biomarkers

9 autores

  • Michael Shechter🇮🇱 · autor de correspondenciaTel Aviv University; Sheba Medical Center
  • Guy Shalmon🇮🇱Tel Aviv University; Sheba Medical Center
  • Mickey Scheinowitz🇮🇱Tel Aviv University; Sheba Medical Center
  • Nira Koren‐Morag🇮🇱Tel Aviv University
  • Micha S. Feinberg🇮🇱Tel Aviv University; Sheba Medical Center
  • Dror Harats🇮🇱Tel Aviv University; Sheba Medical Center
  • Ben Ami Sela🇮🇱Tel Aviv University; Sheba Medical Center
  • Yehonatan Sharabi🇮🇱Tel Aviv University; Sheba Medical Center
  • Pierre Chouraqui🇮🇱Tel Aviv University; Sheba Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Although coffee is a widely used, pharmacologically active beverage, its impact on the cardiovascular system is controversial. To explore the effect of acute caffeine ingestion on brachial artery flow-mediated dilation (FMD) in subjects without coronary artery disease (CAD; controls) and patients with CAD, we prospectively assessed brachial artery FMD in 40 controls and 40 age- and gender-matched patients with documented stable CAD on 2 separate mornings 1 week to 2 weeks apart. After overnight fasting, discontinuation of all medications for ≥12 hours, and absence of caffeine for >48 hours, participants received capsules with caffeine 200 mg or placebo. One hour after drug ingestion, participants underwent brachial artery FMD and nitroglycerin-mediated dilation (NTG) using high-resolution ultrasound. As expected, patients with CAD were more often diabetic, hypertensive, obese, dyslipidemic, and smoked more than controls (p <0.01 for all comparisons). Aspirin, Clopidogrel, angiotensin-converting enzyme inhibitors, β blockers, and statins were significantly more common in patients with CAD than in controls (p <0.01 for all comparisons). At baseline, FMD, but not NTG, was significantly lower in patients with CAD compared to controls. Acute caffeine ingestion significantly increased FMD (patients with CAD 5.6 ± 5.0% vs 14.6 ± 5.0%, controls 8.4 ± 2.9% vs 18.6 ± 6.8%, p <0.001 for all comparisons) but not NTG (patients with CAD 13.0 ± 5.2% vs 13.8 ± 6.1%, controls 12.9 ± 3.9% vs 13.9 ± 5.8%, p = NS for all comparisons) and significantly decreased high-sensitivity C-reactive protein (patients with CAD 2.6 ± 1.4 vs 1.4 ± 1.2 mg/L, controls 3.4 ± 3.0 vs 1.2 ± 1.0 mg/L, p <0.001 for all comparisons) in the 2 groups compared to placebo. In conclusion, acute caffeine ingestion significantly improved endothelial function assessed by brachial artery FMD in subjects with and without CAD and was associated with lower plasma markers of inflammation.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.